Mabxience
Project
Monoclonal antibody plant
Client
Mabxience
Place
Argentina
Sector
Biotechnology
Installed surface
2,800 m2
Mabxience
The monoclonal antibody production facility required a highly controlled environment, where Valtria designed and installed the HVAC system to ensure compliance with ISO 5, ISO 7, and ISO 8 classification standards for key areas, including cell culture, harvesting, and bioreactors. The project also involved the installation of weighing and fractionation areas, as well as general storage facilities.
To support operations, cold and hot water production was implemented using two heat recovery units, providing a total capacity of 1,100 kW. The hydraulic distribution of hot and cold water was also installed, along with reinforced heating production using steam-to-water heat exchangers and a sanitary hot water supply system equipped with additional heat exchangers.
About the project
Additionally, the power supply and control systems for HVAC operations were fully executed by Valtria, including the installation of electrical panels and the commissioning of all services.
Currently, this plant is manufacturing the active pharmaceutical ingredient (API) for AstraZeneca’s SARS-CoV-2 (COVID-19) vaccine, ensuring a high level of quality and compliance with strict biopharmaceutical industry standards.